- Price is above Fair Value, showing premium demand versus the model.
- Latest weekly return ranks in the strongest part of its sector group.
9887
HKG
Week ended 07 Aug 2026
Weekly Investor Report
Nanjing Leads Biolabs Co., Ltd. · Healthcare · Biotechnology
Latest close
64.30 HKD
20.4%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -1.0% below the Trend Line and sits at 37.1% of its 52-week range. The latest completed week returned 20.4%, after a 28.8% four-week move. The latest news-sentiment score is 54/100.
Setup score
45
out of 100
Latest Close
64.30 HKD
7 Aug 2026
1W Return
20.4%
latest completed week
4W Return
28.8%
short-term follow-through
12W Return
1.3%
quarterly tape
Trend Breadth
17.3%
9 of 52 weeks active
Volume Ratio
1.5x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Activity pressure is negative, which weakens the current setup.
- Next-week expectancy is negative at 34.41% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
20.4%
Latest completed week; four-week move 28.8%.
Indicator stack
10/52
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 34.41%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
54/100
10 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -1.0% below the Trend Line and sits at 37.1% of its 52-week range. The latest completed week returned 20.4%, after a 28.8% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.5x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0812-week average 0.44
12-week confirmation
Trend active2/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure1/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership3/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.08Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 28.8% over four weeks, 1.3% over 12 weeks, and -6.5% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year9
Trend breadth17.3%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.23Latest activity-pressure read.
Pressure change74.4%Four-week change in activity pressure.
Leadership2.64Latest relative-leadership reading.
RS change-Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment54/100
Weighted news tone is neutral across 10 relevant articles.
1 positive · 9 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-34.1%Distance below the 52-week high.
13-week volatility12.9%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher12 of 2614 weeks finished lower.
Best week+29.2%Week of 17 Jul.
Worst week-21.3%Week of 15 May.
Latest week+20.4%Week of 7 Aug.
Shape of recent returns
Strong gains8
Modest gains4
Flat weeks0
Modest losses4
Sharp losses10
Recent vol12.9%13-week weekly-return volatility.
Base vol9.5%52-week weekly-return volatility.
Up/down split22/30Count of positive and negative weeks in the 52-week window.
Average skew8.5% / -5.7%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorHK Healthcare
4-week rank4 / 100
Group average4.4%
Trend breadth12.0%
Trend12.0%active weekly trend signals
MD32.0%positive activity pressure
RS19.0%positive relative leadership
Four-week leaders
IndustryHK Biotechnology
4-week rank4 / 77
Group average2.4%
Trend breadth14.3%
Trend14.3%active weekly trend signals
MD24.7%positive activity pressure
RS20.8%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape36/100
Trend, activity pressure, participation, and risk combine to a 36/100 tape read.
Indicator analysis20/100Latest 12-week confirmation: trend 2/12, activity pressure 1/12, relative leadership 3/12.
Activity pressure 0.08; No reversal markers Next-Week ExpectancyNegative 34.41%Next-week expectancy is negative with a 34.41% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment54/100Weighted news tone is neutral across 10 relevant articles.
Nanjing Leads Biolabs Co., Ltd. (9887.HK) stock price, news, quote and history Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 64.30 HKD | 20.4% | 64.92 HKD | 63.06 HKD | -0.23 | 2.64 | 10.9M | Off |
| 31 Jul 2026 | 53.40 HKD | -14.5% | 64.65 HKD | 63.03 HKD | -0.39 | -15.65 | 44.3M | Off |
| 24 Jul 2026 | 62.45 HKD | -3.2% | 64.55 HKD | 63.21 HKD | -0.55 | 1.65 | 6.6M | Off |
| 17 Jul 2026 | 64.50 HKD | 29.2% | 64.13 HKD | 63.23 HKD | -0.71 | 6.59 | 15.2M | Off |
| 10 Jul 2026 | 49.92 HKD | -5.4% | 63.66 HKD | 63.20 HKD | -0.88 | - | 4.4M | Off |
| 3 Jul 2026 | 52.75 HKD | 6.4% | 63.77 HKD | 63.47 HKD | -0.95 | - | 296.3K | Off |
| 26 Jun 2026 | 49.58 HKD | -8.2% | 63.73 HKD | 63.69 HKD | -0.93 | - | 649.0K | Off |
| 19 Jun 2026 | 54.00 HKD | 0.2% | 63.85 HKD | 63.98 HKD | -0.87 | - | 1.9M | Off |
| 12 Jun 2026 | 53.90 HKD | -4.6% | 63.75 HKD | 64.20 HKD | -0.75 | - | 877.8K | Off |
| 5 Jun 2026 | 56.50 HKD | -7.8% | 63.92 HKD | 64.42 HKD | -0.53 | - | 843.0K | Off |
| 29 May 2026 | 61.30 HKD | -4.4% | 63.98 HKD | 64.60 HKD | -0.15 | - | 2.7M | On |
| 22 May 2026 | 64.15 HKD | 1.1% | 63.73 HKD | 64.67 HKD | 0.23 | - | 3.2M | On |
| 15 May 2026 | 63.45 HKD | -21.3% | 63.56 HKD | 64.68 HKD | 0.65 | - | 5.2M | On |
| 8 May 2026 | 80.60 HKD | 0.7% | 63.61 HKD | 64.71 HKD | 1.02 | - | 2.0M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.